Tibsovo 250 mg film-coated tablets
adIVO
Phase 3 small_molecule active
Quick answer
Tibsovo 250 mg film-coated tablets for ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active